Strategic Partnerships and Intellectual Property
Enhancing Science through Collaborations with FDA
FDA is interested in partnering with the stakeholders to further its public health mission. By leveraging resources and expertise, through appropriate mechanisms, FDA can effectively collaborate to address critical public health needs and bridge scientific gaps, thereby stimulating innovation in the products we regulate.
Collaborations can be formalized through multiple mechanisms including, but not limited to Cooperative Research and Development Agreements (CRADAs), contracts, Cooperative agreements, or through innovative public-private partnerships.
FDA will give preference to ideas and proposals which will enhance the delivery of mission-related FDA functions and do not require funding from the FDA.